You are here

17-12-2019 | Portrait image © University of Helsinki - Illustration: Legend: The new artificially cloaked viral-based nanovaccines for cancer immunotherapeutic applications. © University of Helsinki
A targeted and personalised method for triggering the body’s immune response could transform how we treat cancer. Thanks to a grant from the European Research Council (ERC), an inspired idea has been developed in the lab and turned into a ground-breaking commercial opportunity.
14-06-2015 | Portrait: © Prof. Päivi Peltomäki | Image: © www.istockphoto.com
Prevention and early detection largely determine the outcome of most cancers. Prof. Päivi Peltomäki studies how tumours arise and progress, with a view to identifying biomarkers of our susceptibility to developing cancer. With the ERC grant, the team has created a single-step, early diagnosis kit for colorectal cancer.